Eyetech Holders Eye FDA Panel
233864
Eyetech Pharmaceuticals (EYET:Nasdaq - news - research) faces an important regulatory test Aug. 27 when a Food and Drug Administration advisory panel will review Macugen, the company&#39;s experimental drug intended
305997
The Securities and Exchange Commission is scrutinizing biotechnology companies as part of a wider effort to ensure that companies don&#39;t mislead investors
448573
A document released by the FDA outlines its concerns with GPC's lead drug.
2234
Makers of the arthritis drug Vioxx and the FDA are the subject of Senate scrutiny today...and an Iowa Senator is asking the tough questions.
268363
GAITHERSBURG, Maryland  - The Food and Drug Administration should consider telling patients and doctors that the use of drug-coated heart stents in unapproved, high-risk cases can lead to greater complications, a panel of medical experts said on Friday.
573933
European and U.S. regulators said Tuesday they have been investigating a possible cartel involving makers of liquid crystal display monitors.
639313
Six physicians with financial ties to Johnson &amp; Johnson and other heart-device makers will be advising US regulators whether to restrict the use of some products because of potentially lethal side effects.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
142237
Company's employees have been posting their thoughts on tech topics.
287660
In a hearing on the national flu vaccine shortage, the House Energy and Commerce Subcommittee on Health on Thursday requested that FDA, HHS and flu vaccine manufacturer Chiron by Dec. 1 produce documents detailing
316579
Yesterday Proctor &amp; Gamble&#39;s (NYSE: PG) Intrinsa went in front of the FDA&#39;s Advisory Committee for Reproductive Health Drugs.
629222
Investors expecting a formal vote from a Food and Drug Administration panel Friday on Eyetech Pharmaceuticals Inc.&#39;s age-related blindness treatment Macugen may have been disappointed as shares of the stock fell after the meeting.
372828
An advisory panel to the Food and Drug Administration will meet today to decide whether a skin patch to heighten the sexual arousal of older women is safe and effective and should be licensed as a new drug.
566909
The FDA decides to debate the company's lead drug.
337162
Biotech company Eyetech Pharmaceuticals Inc. said it is optimistic about the Food and Drug Administration&#39;s advisory panel review for its age-related blindness treatment Macugen.
247888
AstraZeneca will defend its new prescription drug Exanta before a federal panel today after new questions were raised about the safety and effectiveness of the stroke prevention medication.
207004
Industry experts join government panel to look at what's keeping the old-fashioned bar code around.